BCRX stock
why Biocryst Pharmaceuticals Inc [BCRX] is a Good Choice for Investors After New Price Target of $20.09
Annabelle Farmer
Biocryst Pharmaceuticals Inc [NASDAQ: BCRX] closed the trading session at $6.86 on 2025-11-03. The day’s price range saw the stock ...
TD Cowen slashes price target on Biocryst Pharmaceuticals Inc [BCRX] – find out why.
Brandon Evans
Biocryst Pharmaceuticals Inc [NASDAQ: BCRX] slipped around -0.06 points on Thursday, while shares priced at $7.25 at the close of ...
Biocryst Pharmaceuticals Inc [BCRX] Revenue clocked in at $557.51 million, down -9.83% YTD: What’s Next?
Annabelle Farmer
Biocryst Pharmaceuticals Inc [NASDAQ: BCRX] loss -8.81% or -0.62 points to close at $6.42 with a heavy trading volume of ...
Biocryst Pharmaceuticals Inc [BCRX] moved up 4.75: Why It’s Important
Annabelle Farmer
Biocryst Pharmaceuticals Inc [NASDAQ: BCRX] price surged by 4.75 percent to reach at $0.33. A sum of 5780229 shares traded ...
Market cap of Biocryst Pharmaceuticals Inc [BCRX] reaches 1.55B – now what?
Caleb Clifford
Biocryst Pharmaceuticals Inc [NASDAQ: BCRX] stock went on a downward path that fall over -2.90% on Wednesday, amounting to a ...
